Pharmacokinetics and pharmacodynamics of meropenem in elderly chinese with lower respiratory tract infections: Population pharmacokinetics analysis using nonlinear mixed-effects modelling and clinical pharmacodynamics study

Drugs and Aging

Volumn 28, Issue 11, 2011, Pages 903-912

  Zhou, Q T ^a   He, Bei ^a   Zhang, Chao ^a   Zhai, S D ^a   Liu, Z Y ^a   Zhang, Jie ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Antibacterials; Elderly; Meropenem; Respiratory tract infections

Indexed keywords

ALBUMIN; MEROPENEM;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CHINESE; COMPUTER PROGRAM; DRUG BLOOD LEVEL; EPSILOMETER TEST; FEMALE; GERIATRIC PATIENT; GRAM NEGATIVE BACTERIUM; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SPUTUM; TRACHEAL ASPIRATION PROCEDURE; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; NONLINEAR DYNAMICS; RESPIRATORY TRACT INFECTIONS; THIENAMYCINS;

EID: 80755126031     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/11595960-000000000-00000     Document Type: Article

References (27)

1. Capelastegui A, Espana PP, Bilbao A, et al. Study of community-acquired pneumonia: incidence, patterns of care, and outcomes in primary and hospital care. J Infect 2010 Nov; 61 (5): 364-71
2. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005 Feb; 171 (4): 388-416
3. Song JH. Asian Hospital Acquired Pneumonia Working Group. Treatment recommendations of hospital-acquired pneumonia in Asian countries: first consensus report by the Asian HAP Working Group. Am J Infect Control 2008 May; 36 (4 Suppl.): S83-92
4. Torres A, Ewig S, Lode H, et al. Defining, treating and preventing hospital acquired pneumonia: European perspective. Intensive Care Med 2009 Jan; 35 (1): 9-29
5. Li C, Kuti JL, Nightingale CH, et al. Population phar-macokinetic analysis and dosing regimen optimization of meropenem in adult patients. J Clin Pharmacol 2006 Oct; 46 (10): 1171-8 (Pubitemid 44387417)
6. Lee DG, Choi SM, Shin WS, et al. Population pharmaco-kinetics of meropenem in febrile neutropenic patients in Korea. Int J Antimicrob Agents 2006 Oct; 28 (4): 333-9
7. Ikawa K, Morikawa N, Ikeda K, et al. Population phar-macokinetics and pharmacodynamics of meropenem in Japanese pediatric patients. J Infect Chemother 2010 Apr; 16 (2): 139-43
8. van den Anker JN, Pokorna P, Kinzig-Schippers M, et al. Meropenem pharmacokinetics in the newborn. Antimicrob Agents Chemother 2009 Sep; 53 (9): 3871-9
9. Bradley JS, Sauberan JB, Ambrose PG, et al. Meropenem pharmacokinetics, pharmacodynamics, and Monte Carlo simulation in the neonate. Pediatr Infect Dis J 2008 Sep; 27 (9): 794-9
10. Du X, Li C, Kuti JL, et al. Population pharmacokinetics and pharmacodynamics of meropenem in pediatric patients. J Clin Pharmacol 2006 Jan; 46 (1): 69-75 (Pubitemid 43021715)
11. Doh K, Woo H, Hur J, et al. Population pharmacokinetics of meropenem in burn patients. J Antimicrob Chemother 2010 Nov; 65 (11): 2428-35
12. Isla A, Rodriguez-Gascon A, Troconiz IF, et al. Population pharmacokinetics of meropenem in critically ill patients undergoing continuous renal replacement therapy. Clin Pharmacokinet 2008; 47 (3): 173-80
13. Roberts JA, Kirkpatrick CM, Roberts MS, et al. Mer-openem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution. J Antimicrob Che-mother 2009 Jul; 64 (1): 142-50
14. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005 Dec; 26 (6): 1138-80 (Pubitemid 41829947)
15. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveil-lance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008 Jun; 36 (5): 309-32 (Pubitemid 351763841)
16. Cockcroft DW, Gault MH. Prediction of creatinine clear-ance from serum creatinine. Nephron 1976; 16 (1): 31-41
17. Drusano GL, Hutchison M. The pharmacokinetics of mer-openem. Scand J Infect Dis Suppl 1995; 96: 11-6
18. Elmadfa I, Meyer AL. Body composition, changing phy-siological functions and nutrient requirements of the elderly. Ann Nutr Metab 2008; 52 Suppl. 1: 2-5 (Pubitemid 351496696)
19. Craig WA. The pharmacology of meropenem, a new car-bapenem antibiotic. Clin Infect Dis 1997 Feb; 24 Suppl. 2: S266-75 (Pubitemid 27130716)
20. Ariano RE, Nyhlen A, Donnelly JP, et al. Pharmacokinetics and pharmacodynamics of meropenem in febrile neu-tropenic patients with bacteremia. Ann Pharmacother 2005 Jan; 39 (1): 32-8 (Pubitemid 40052375)
21. Li C, Du X, Kuti JL, et al. Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections. Antimicrob Agents Chemother 2007 May; 51 (5): 1725-30 (Pubitemid 46744151)
22. Koromath FS, Sumarmi, Hermawan AG. Infectious disease pattern and serum albumin levels in elderly people hospitalized at Dr. Moewardi Hospital Surakarta during 2004. Acta Med Indones 2008 Jul; 40 (3): 114-6
23. Agullo-Ortuno MT, Garcia-Mancebo ML, Montes-Ares O, et al. Biochemical and immunologic features of an outbreak of Legionnaires disease: comparative study between community-acquired pneumonias. Diagn Microbiol Infect Dis 2006 Sep; 56 (1): 7-11 (Pubitemid 44404005)
24. Hung PP, Lin YH, Lin CF, et al. Chryseobacterium me-ningosepticum infection: antibiotic susceptibility and risk factors for mortality. J Microbiol Immunol Infect 2008 Apr; 41 (2): 137-44
25. Wells M, Lipman J. Measurements of glomerular filtration in the intensive care unit are only a rough guide to renal function. S Afr J Surg 1997 Feb; 35 (1): 20-3 (Pubitemid 27197471)
26. Pong S, Seto W, Abdolell M, et al. 12-hour versus 24-hour creatinine clearance in critically ill pediatric patients. Pe-diatr Res 2005 Jul; 58 (1): 83-8 (Pubitemid 40967434)
27. Herrera-Gutierrez ME, Seller-Perez G, Banderas-Bravo E, et al. Replacement of 24-h creatinine clearance by 2-h creatinine clearance in intensive care unit patients: a single-center study. Intensive Care Med 2007 Nov; 33 (11): 1900-6 (Pubitemid 47632255)